indazoles has been researched along with Disease, Pulmonary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enkhbaatar, P; Hamahata, A; Lange, M; Nakano, Y; Traber, DL; Traber, LD | 1 |
| Abramova, E; Atochina-Vasserman, EN; Ersumo, NT; Gow, AJ; Guo, CJ; James, ML; Krymskaya, VP; Liu, AY; Rue, R | 1 |
| Brown, DG; Chrencik, JE; Coe, JW; Dehnhardt, CM; England, KS; Jones, P; Jones, RM; Kilty, I; Kortum, SW; Morgan, P; Mukaiyama, T; Murphy, JR; Sabnis, YA; Storer, RI; Wakenhut, FM; Whitlock, GA; Yeoh, T | 1 |
| Chang, WD; Chang, YW; Chung, PJ; Fang, YC; Hwang, TL; Kuo, LM; Tang, MC | 1 |
| Cox, R; Enkhbaatar, P; Hawkins, H; Herndon, D; Jodoin, J; Lee, S; McGuire, R; Mizutani, A; Murakami, K; Schmalstieg, F; Shimoda, K; Traber, D; Traber, L | 1 |
| Camillo, MA; Troncone, LR; Yonamine, CM | 1 |
6 other study(ies) available for indazoles and Disease, Pulmonary
| Article | Year |
|---|---|
Heterogeneity of the effects of combined nitric oxide synthase inhibition on organ perfusion in ovine sepsis.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Ileum; Indazoles; Lung Diseases; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Pancreas; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Regional Blood Flow; Sepsis; Sheep; Sheep Diseases; Smoke Inhalation Injury; Spleen | 2013 |
Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis.
Topics: Animals; Axitinib; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Disease Models, Animal; Female; Imidazoles; Indazoles; Lung; Lung Diseases; Lung Neoplasms; Lymphangioleiomyomatosis; Mice; Mice, Inbred C57BL; Mice, Nude; Nitric Oxide Synthase Type II; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Up-Regulation; Vascular Endothelial Growth Factor D | 2015 |
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin.
Topics: Administration, Cutaneous; Administration, Inhalation; Animals; Anti-Inflammatory Agents; Binding Sites; Crystallography, X-Ray; Dogs; Drug Design; Hepatocytes; Heterocyclic Compounds, 2-Ring; Humans; Indazoles; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Janus Kinases; Lung Diseases; Mice, Inbred BALB C; Microsomes, Liver; Phosphorylation; Protein Kinase Inhibitors; Rats; Skin Diseases; Solubility | 2017 |
YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
Topics: Animals; Colforsin; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Enzyme Activators; Guanylate Cyclase; Immunoblotting; Indazoles; Isoquinolines; Lung Diseases; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphoric Diester Hydrolases; Rats; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Sulfonamides | 2012 |
Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model.
Topics: Acute Disease; Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Guanidines; Indazoles; Lung Diseases; Nitric Oxide Synthase; omega-N-Methylarginine; Pneumonia, Bacterial; Sheep, Domestic; Smoke | 2003 |
Blockade of neuronal nitric oxide synthase abolishes the toxic effects of Tx2-5, a lethal Phoneutria nigriventer spider toxin.
Topics: Analysis of Variance; Animals; Enzyme Inhibitors; Indazoles; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Neuropeptides; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Priapism; Spider Venoms; Spiders | 2004 |